BP Plastics Holding Bhd. (KLSE:BPPLAS)
Malaysia · Delayed Price · Currency is MYR 0.8700
-0.0150 (-1.69%)
At close: Aug 1, 2025
CTI BioPharma Income Statement
Financials in millions MYR. Fiscal year is January - December.
Millions MYR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
| 477.22 | 487.68 | 469.6 | 502.59 | 447.13 | 316.6 | Upgrade | |
Revenue Growth (YoY) | 0.15% | 3.85% | -6.57% | 12.40% | 41.23% | -4.41% | Upgrade |
Cost of Revenue | 446.01 | 446.01 | 416.94 | 454.03 | 378.76 | 267.63 | Upgrade |
Gross Profit | 31.21 | 41.67 | 52.66 | 48.56 | 68.37 | 48.97 | Upgrade |
Selling, General & Admin | 19.7 | 19.7 | 14.87 | 14.25 | 13.93 | 12.18 | Upgrade |
Operating Expenses | 12.14 | 19.41 | 14.57 | 14.87 | 13.93 | 12.02 | Upgrade |
Operating Income | 19.07 | 22.26 | 38.08 | 33.69 | 54.44 | 36.95 | Upgrade |
Interest & Investment Income | 2.21 | 2.21 | 1.82 | 0.86 | 1.23 | 1.42 | Upgrade |
Currency Exchange Gain (Loss) | 0.08 | 0.08 | 1.37 | 0.15 | 0.49 | 0.17 | Upgrade |
Other Non Operating Income (Expenses) | 0.5 | 0.87 | 0.56 | 0.99 | 0.58 | 0.29 | Upgrade |
EBT Excluding Unusual Items | 21.86 | 25.42 | 41.84 | 35.68 | 56.75 | 38.82 | Upgrade |
Gain (Loss) on Sale of Investments | 0.56 | 0.56 | 0.66 | 0.18 | - | - | Upgrade |
Gain (Loss) on Sale of Assets | 0.03 | 0.03 | 0.12 | 0.15 | 0.02 | 0.1 | Upgrade |
Pretax Income | 22.45 | 26 | 42.62 | 36.01 | 56.77 | 38.92 | Upgrade |
Income Tax Expense | 3.99 | 4.41 | 7.39 | 5.47 | 10.3 | 9.26 | Upgrade |
Net Income | 18.46 | 21.6 | 35.23 | 30.54 | 46.47 | 29.66 | Upgrade |
Net Income to Common | 18.46 | 21.6 | 35.23 | 30.54 | 46.47 | 29.66 | Upgrade |
Net Income Growth | -46.58% | -38.70% | 15.38% | -34.28% | 56.66% | 39.88% | Upgrade |
Shares Outstanding (Basic) | 281 | 281 | 281 | 281 | 281 | 281 | Upgrade |
Shares Outstanding (Diluted) | 281 | 281 | 281 | 281 | 281 | 281 | Upgrade |
EPS (Basic) | 0.07 | 0.08 | 0.13 | 0.11 | 0.17 | 0.11 | Upgrade |
EPS (Diluted) | 0.07 | 0.08 | 0.13 | 0.11 | 0.17 | 0.11 | Upgrade |
EPS Growth | -46.58% | -38.71% | 15.38% | -34.28% | 56.66% | 39.88% | Upgrade |
Free Cash Flow | 7.84 | -1.93 | 20.27 | 15.26 | -9.36 | 52.59 | Upgrade |
Free Cash Flow Per Share | 0.03 | -0.01 | 0.07 | 0.05 | -0.03 | 0.19 | Upgrade |
Dividend Per Share | 0.055 | 0.060 | 0.060 | 0.055 | 0.040 | 0.053 | Upgrade |
Dividend Growth | -8.33% | - | 9.09% | 37.84% | -25.14% | 33.25% | Upgrade |
Gross Margin | 6.54% | 8.54% | 11.21% | 9.66% | 15.29% | 15.47% | Upgrade |
Operating Margin | 4.00% | 4.56% | 8.11% | 6.70% | 12.18% | 11.67% | Upgrade |
Profit Margin | 3.87% | 4.43% | 7.50% | 6.08% | 10.39% | 9.37% | Upgrade |
Free Cash Flow Margin | 1.64% | -0.40% | 4.32% | 3.04% | -2.09% | 16.61% | Upgrade |
EBITDA | 34.53 | 37.42 | 51.6 | 45.1 | 64.72 | 48.18 | Upgrade |
EBITDA Margin | 7.24% | 7.67% | 10.99% | 8.97% | 14.47% | 15.22% | Upgrade |
D&A For EBITDA | 15.46 | 15.17 | 13.52 | 11.4 | 10.28 | 11.23 | Upgrade |
EBIT | 19.07 | 22.26 | 38.08 | 33.69 | 54.44 | 36.95 | Upgrade |
EBIT Margin | 4.00% | 4.56% | 8.11% | 6.70% | 12.18% | 11.67% | Upgrade |
Effective Tax Rate | 17.75% | 16.95% | 17.34% | 15.19% | 18.15% | 23.80% | Upgrade |
Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.